Dr. Teresa Purzner (Kingston Health Sciences Centres and Queen’s University) has been named one of the recipients of the 2025 Clinician-Scientist Awards, for her project titled: “Investigating biomarkers of migration and predictors of recurrence in glioblastoma“. Funded by the Marathon of Hope Cancer Centres Network (MOHCCN), she will receive $450,000 ($225,000 from the Network and $225,000 in matching funds) to support groundbreaking research in precision oncology.
About the award
The MOHCCN Clinician-Scientist Award provides outstanding early-career clinician-scientists with funding to support high-quality research in precision oncology. The award is designed to support early-career investigators as they develop their careers as independent clinician-scientists, in close collaboration and mentorship with established MOHCCN-funded teams.
MOH announcement can be found here:
More information on Dr. Purzner’s Research Project:
